ES2061748T3 - Alcanoil y aroil oxazolonas cardiotonicas. - Google Patents

Alcanoil y aroil oxazolonas cardiotonicas.

Info

Publication number
ES2061748T3
ES2061748T3 ES89102496T ES89102496T ES2061748T3 ES 2061748 T3 ES2061748 T3 ES 2061748T3 ES 89102496 T ES89102496 T ES 89102496T ES 89102496 T ES89102496 T ES 89102496T ES 2061748 T3 ES2061748 T3 ES 2061748T3
Authority
ES
Spain
Prior art keywords
alcanoil
aroil
oxazolones
cardiotonic
cardiotonics
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES89102496T
Other languages
English (en)
Inventor
Richard Schnettler
Richard C Dage
Winton D Jones
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Aventis Pharmaceuticals Inc
Original Assignee
Merrell Dow Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merrell Dow Pharmaceuticals Inc filed Critical Merrell Dow Pharmaceuticals Inc
Application granted granted Critical
Publication of ES2061748T3 publication Critical patent/ES2061748T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/30—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D263/34—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D263/36—One oxygen atom
    • C07D263/38—One oxygen atom attached in position 2
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cardiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)

Abstract

LA INVENCION SE REFIERE A ALCANOIL - O AROIL - OXAZOLONAS QUE MEJORAN LA FUERZA CONTRACTIL DEL MIOCARDIO Y SON UTILES COMO CARDIOTONICOS EN EL TRATAMIENTO DE FALLOS CARDIACOS.
ES89102496T 1988-02-18 1989-02-14 Alcanoil y aroil oxazolonas cardiotonicas. Expired - Lifetime ES2061748T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/157,430 US4866182A (en) 1988-02-18 1988-02-18 Cardiotonic alkanoyl and aroyl oxazolones

Publications (1)

Publication Number Publication Date
ES2061748T3 true ES2061748T3 (es) 1994-12-16

Family

ID=22563682

Family Applications (1)

Application Number Title Priority Date Filing Date
ES89102496T Expired - Lifetime ES2061748T3 (es) 1988-02-18 1989-02-14 Alcanoil y aroil oxazolonas cardiotonicas.

Country Status (19)

Country Link
US (1) US4866182A (es)
EP (1) EP0329070B1 (es)
JP (1) JP2811577B2 (es)
KR (1) KR960014794B1 (es)
CN (1) CN1022035C (es)
AT (1) ATE99681T1 (es)
AU (1) AU614029B2 (es)
CA (1) CA1334201C (es)
DE (1) DE68911944T2 (es)
DK (1) DK74889A (es)
ES (1) ES2061748T3 (es)
FI (1) FI890694A7 (es)
HU (1) HU206880B (es)
IL (1) IL89302A (es)
NO (1) NO890681L (es)
NZ (1) NZ227977A (es)
PH (1) PH26260A (es)
PT (1) PT89749B (es)
ZA (1) ZA891111B (es)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5437491A (en) * 1994-04-07 1995-08-01 Illinois Tool Works Inc. Fuel door housing
DE4429461A1 (de) * 1994-08-19 1996-02-22 Merck Patent Gmbh Adhäsionsrezeptor-Antagonisten
ES2125161B1 (es) 1996-03-21 1999-11-16 Grupo Farmaceutico Almirall S Nuevos derivados de 2-(3h)-oxazolona.
CN102993075A (zh) * 2012-11-29 2013-03-27 江苏长青农化股份有限公司 硫脲类杀虫杀螨剂丁醚脲的合成工艺
WO2016196771A1 (en) 2015-06-03 2016-12-08 Bristol-Myers Squibb Company 4-hydroxy-3-(heteroaryl)pyridine-2-one apj agonists for use in the treatment of cardiovascular disorders

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3514465A (en) * 1966-12-30 1970-05-26 Degussa Certain thiazolyl- and pyridinylaminoketones
US4303439A (en) * 1979-10-01 1981-12-01 Monsanto Company 2-Substituted-4-alkyl or trihaloalkyl-5-oxazolecarboxylic acids as safening agents
JPS59100977A (ja) * 1982-12-01 1984-06-11 Omron Tateisi Electronics Co 記録情報出力方法
DE3246957A1 (de) * 1982-12-18 1984-06-20 Varta Batterie Ag, 3000 Hannover Galvanisches element
CH0114263H2 (en) * 1982-12-18 1998-09-30 Hans Rinninger U. Sohn Gmbh U.Co. Paving block.
US4623651A (en) * 1985-10-15 1986-11-18 Merrell Dow Pharmaceuticals Inc. Cardiotonic heterocyclocarbonyl- and acetyl-thiazolones
US4762849A (en) * 1985-10-15 1988-08-09 Merrell Dow Pharmaceuticals Inc. Cardiotonic alkanoylthiazolones
CA1266268A (en) * 1985-10-15 1990-02-27 J. Martin Grisar Cardiotonic aroylthiazolones
US4670450A (en) * 1985-11-13 1987-06-02 Merrell Dow Pharmaceuticals Inc. Cardiotonic thiazolones
US4728661A (en) * 1985-11-13 1988-03-01 Merrell Dow Pharmaceuticals Inc. Cardiotonic phenyl oxazolones
US4689353A (en) * 1986-02-21 1987-08-25 The Dow Chemical Company Hydroxy and amino-functional polyahls containing carbonate, urethane and/or urea moieties

Also Published As

Publication number Publication date
EP0329070B1 (en) 1994-01-05
IL89302A (en) 1993-02-21
FI890694A0 (fi) 1989-02-14
KR960014794B1 (en) 1996-10-19
EP0329070A1 (en) 1989-08-23
NZ227977A (en) 1990-10-26
DK74889D0 (da) 1989-02-17
JP2811577B2 (ja) 1998-10-15
NO890681D0 (no) 1989-02-17
DE68911944D1 (de) 1994-02-17
DE68911944T2 (de) 1994-05-19
KR890012983A (ko) 1989-09-20
PT89749B (pt) 1994-03-31
PT89749A (pt) 1989-10-04
CN1036761A (zh) 1989-11-01
ATE99681T1 (de) 1994-01-15
FI890694A7 (fi) 1989-08-19
CN1022035C (zh) 1993-09-08
CA1334201C (en) 1995-01-31
HU206880B (en) 1993-01-28
AU2990689A (en) 1989-08-24
DK74889A (da) 1989-08-19
HUT54148A (en) 1991-01-28
US4866182A (en) 1989-09-12
PH26260A (en) 1992-04-01
NO890681L (no) 1989-08-21
AU614029B2 (en) 1991-08-15
ZA891111B (en) 1989-10-25
IL89302A0 (en) 1989-09-10
JPH02149571A (ja) 1990-06-08

Similar Documents

Publication Publication Date Title
ES2074867T3 (es) Derivados de quinazolina para potenciar la actividad antitumoral.
IT942190B (it) Stimolatore bioelettrico parti colarmente per applicazioni al cuore
ES2187497T3 (es) Promotores preferentemente en tejidos.
ATE79730T1 (de) Bekleidungsstueck, das eine gute feuchtigkeitsabfuehrung sichert.
ES2134315T3 (es) Regulador de tension para marcapasos cardiaco.
ES2092981T3 (es) Derivados de aristeromicina/adenosina.
ES2061748T3 (es) Alcanoil y aroil oxazolonas cardiotonicas.
ES2036518T3 (es) Un procedimiento para preparar una oxazolona heterociclica.
FI864597A0 (fi) Kardiotoniska tiazoloner.
ES2083418T3 (es) Preparaciones polimeras acuosas.
ATE59781T1 (de) Potenzierung von prazosin.
ES2117129T3 (es) Hidrogeles de polieteramidoamina como materiales heparinizables.
DE3686472D1 (de) Cardiotonische phenyloxazolone.
ES2171704T3 (es) Peptidos ciclicos analogos de somatostatina con actividad inhibidora sobre la hormona del crecimiento.
ES2053621T3 (es) Un procedimiento para preparar ciertas oxazolonas triciclicas cardiotonicas.
ES2066422T3 (es) Expresion de un arn multigenes con actividad de autoempalme.
ES2052036T3 (es) Producto textil termoadhesivo reticulable.
AR240063A1 (es) Procedimiento para la produccion del activador del plasminogeno del tejido humano mediante el cultivo de la cepa de celulas registrada como kym-sf ifo 50135.
BE604777A (fr) Compositions therapeutiques hypotensives.
Spielrein Ergonomics: An art or a science.
BR6905758D0 (pt) Processo de aperfeicoamento das propriedades adesivas de couro artificial
NL144005B (nl) Werkwijze voor het modificeren van de eigenschappen van een keratinevezels bevattend weefsel of breisel.
FR1118M (fr) La catalase, son introduction en thérapeutique humaine comme accélérateur de la fibrogenese.
ES87514U (es) Mueble combinado mesa-bar
GB548889A (en) Improvements in or relating to the manufacture of coffee essence and the like

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 329070

Country of ref document: ES